Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47.9M
-
Number of holders
-
176
-
Total 13F shares, excl. options
-
51.8M
-
Shares change
-
+772K
-
Total reported value, excl. options
-
$1.88B
-
Value change
-
+$32.1M
-
Number of buys
-
86
-
Number of sells
-
-85
-
Price
-
$36.21
Significant Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q3 2016
198 filings reported holding HAE - HAEMONETICS CORP - Common Stock as of Q3 2016.
HAEMONETICS CORP - Common Stock (HAE) has 176 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51.8M shares
.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (5.5M shares), VANGUARD GROUP INC (4.19M shares), BlackRock Fund Advisors (3.62M shares), WELLINGTON MANAGEMENT GROUP LLP (3.4M shares), WELLS FARGO & COMPANY/MN (2.35M shares), FULLER & THALER ASSET MANAGEMENT, INC. (2.12M shares), VICTORY CAPITAL MANAGEMENT INC (1.96M shares), Neuberger Berman Group LLC (1.88M shares), DIMENSIONAL FUND ADVISORS LP (1.77M shares), and Van Berkom & Associates Inc. (1.4M shares).
This table shows the top 176 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.